Categorization of psychosocial factors associated with adherence to antihypertensive drugs;Categorización de factores psicosociales asociados al cumplimiento farmacológico anthipertensivo

Psicothema

Volumn 15, Issue 1, 2003, Pages 82-87

  Rodríguez, Silvia Fernández ^a   González, Ma Luisa López ^a,b   Fuentes, Ángel Comas ^a   Cueto, Eduardo García ^a   Espinar, Antonio Cueto ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037281039     PISSN: 02149915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Amigo I, Fernández A. González A, Herrera J. (2002). Muscle relaxation and continuous ambulatory blood pressure in mild hypertension. Psicothema, 14, 47-52.
2. Black HR. (1999). Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited. Am J Hypertens, 12 (12 Pt 3), 225S-30S.
3. Burg J, Lechner L, de Vries H. (1995). Psychosocial Determinants of fruit and vegetable consumption. Appetite, 25, 285-96.
4. Burnard P. (1991). A method of analysing interview transcripts in qualitative research. Nurse Educ Today, 11, 461-6.
5. Burnier M. (2000). Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension. Blood Press Monit, 5 Suppl 1, S31-4.
6. Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A. (1998). Adherence to pharmacologic management of hypertension. Can J Public Health, 89 (5), 16-8.
7. Fishbein M, Ajzen I. (1975). Belief, Attitude, Intention and Behavior: an introduction to theory and research. Addison-Wesley: Reading MA.
8. Fishman T. (1995). The 90-Second intervention: a patient compliance mediated technique to improve and control hypertension. Pub Health Rep, 110, 173-8.
9. Flack JM, Novikov SV, Ferrario CM. (1996). Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J, 17 Suppl A, 16-20.
10. Gasse C, Stieber J, Doring A, Keil U, Hense HW. (1999). Population trends in antihypertensive drug use: results from the MONICA Augsburg Project 1984 to 1995. J Clin Epidemiol, 52 (7), 695-703.
11. Grueninger UJ, Goldstein MG, Duffy FD. (1989). Patient education in hypertension: five essential steps. J Hypertens Suppl, 7 (3), S93-8.
12. Grueninger V. Arterial Hypertension: lessons from patient education. (1995). Patient Educ Couns, 26, 37-55.
13. Harding G, Gantley M. (1998). Qualitative methods: beyond the cookbook. Family Practice, 15, 76-9.
14. Johnson BF, Hamilton G, Fink J, Lucey G, Bennet N, Lew R. (2000). A design for testing interventions to improve adherence within a hypertension clinical trial. Control Clin Trials, 21 (1), 62-72.
15. Kaplan NM. (2000). Guidelines for the management of hypertension. Can J Cardiol, 16 (9), 1147-52.
16. Kjellgren KI, Ahlner J, Dahlof B, Gill H, Hedner T, Saljo R. (1998). Patients' and physicians' assessment of risks associated with hypertension and benefits from treatment. J Cardiovasc Risk, 5 (3), 161-6.
17. Krueger RA. (1991). El grupo de discusión. Guía práctica para la investigación aplicada. Madrid: Ed Pirámide.
18. Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Baguet P et al. (1995). Comportement des patients ayant une hypertension arterielle legere a moderee vis-a-vis de leur traitement. Apport du pilulier electronique. Ann Cardiol Angeiol, 44 (10), 597-605.
19. Martínez A. (1993). La observancia en el tratamiento de la hipertensión arterial. Barcelona: Ed Doyma.
20. Mays N, Pope C. (2000). Qualitative research in Health Care. Assesing quality in qualitative research. BMJ, 320, 50-2.
21. McKinlay JB. (1992). Health Promotion through healthy public policy: the contribution of complementary research methods. Can J Pub Health, 83suppl1, S11-9.
22. Miles M, Huberman A. (1984). Qualitative data analysis. A sourcebook of new methods. California: Sage Publications Inc.
23. Muñiz J. (1998). Teoría clásica de los test. Madrid: Pirámide.
24. Nichols-English G, Poirier S. (2000). Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc, 40 (4), 475-85.
25. Piñeiro F, Gil V, Donis M, Orozco D, Pastor R, Merino J. (1997). Factores implicados en el cumplimiento del tratamiento farmacológico en la hipertensión arterial. Atención Primaria, 20 (4), 180-4.
26. Piñeiro F, Gil V, Donis M, Orozco D, Pastor R, Merino J. (1998). Relación entre el cumplimiento del tratamiento farmacológico y el grado de control en pacientes con hipertensión arterial, diabetes no insulinodependientes y dislipemias. Med Clin, 111, 566-7.
27. Pope C, Ziebland S, Mays N. (2000). Qualitative research in health care. Analysing qualitative data. BMJ, 320, 114-6.
28. Prochaska J, DiClemente C. (1984). The transtheoretical approach. Crossing traditional boundaries of therapy. Illinois: Down Jones-Irwin.
29. Puras A, Sanchís C, Artigao LM, Divison JA (1998). Prevalence, awareness, treatment, and control of hypertension in a Spanish population. Eur J Epidemiol, 14(1), 31-6.
30. Shaw E, Anderson JG, Maloney M, Jay SJ, Fagan D. (1995). Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm, 30 (3), 201-7.
31. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. (1992). Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health, 82 (12), 1607-12.
32. Waeber B, Burnier M, Brunner HR. (2000). How to improve adherence with prescribed treatment in hypertensive patients? J Cardiovasc Pharmacol, 35 Suppl 3, S23-6.
33. Willey C. (1999). Behavior-changing methods for improving adherence to medication. Curr Hypertens Rep, 1 (6), 477-81.